We use cookies to analyze traffic, provide social media features and to personalise ads.

Read our Cookie Policy

We use cookies to analyze traffic, provide social media features and to personalise ads.

Read our Cookie Policy Close
'
Updated: 05/25/2017 04:39 PM | First Published: 05/23/2017 01:33 PM

Mylan CEO Heather Bresch testifies at a hearing on EpiPen price hike

Heather Bresch, the CEO of Mylan, the pharmaceutical company that produces EpiPen, at a hearing regarding its increasing price.

Heather Bresch, is often criticized for taking the advantage of people's illness since an important medication EpiPen is subject to price increase every year. Since 2007, its price has increased by 500%.







Prev 1 of 4 Sia's sixth album, 1000 Forms of Fear, was her international breakthrough Next